More than $1 billion in support for projects across the country OTTAWA, ON — /CNW/ — Scientists and researchers play an integral role in helping to build a stronger, healthier and more resilient… Read More
Targeting neurodegenerative diseases such as Alzheimer’s, Huntington’s and Parkinson’s Identified two lead cannabinoid analog compounds for in vivo studies NSERC grant funding supports InMed’s collaborative research projects with Dr. Kumar… Read More
INOVAIT currently has an open call for applications for its $125,000 Pilot Fund. The program offers funding to support collaborative commercialization-focused research and development projects involving the integration of artificial intelligence… Read More
VANCOUVER, BC — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that it has… Read More
VANCOUVER, BC — Thrive Health has been ranked #1 in Deloitte’s 2022 Technology Fast 50 Companies to Watch list. Celebrating its 25th anniversary, the award recognizes emerging companies based on… Read More
